CHELSEY LUKE: Open Payments
NPI 1255099388 · GIBSON CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 9 companies in 2025. Trend: 2023 $167 · 2024 $359 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| Insulet Corporation | 1 | $31 |
| PFIZER INC. | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $14 |
Products named: AIRSUPRA, UBRELVY, JARDIANCE, Omnipod, ELIQUIS, Ozempic, Jornay PM, Rybelsus.
Industry payments across IL — which companies pay providers there.
